Nimble Therapeutics Email Format

Biotechnology ResearchWisconsin, United States11-50 Employees

Nimble Therapeutics is a biotechnology company focused on developing oral peptide therapeutics. It operates a proprietary discovery and development engine that combines experimental discovery with data-driven methods to identify and optimize peptide drugs. The company advances its internal pipeline while also supporting several partnered programs, reflecting ongoing collaboration with external biopharma developers.

Based in Madison, Wisconsin, Nimble Therapeutics sits in the biotechnology research sector and serves pharmaceutical and biotech customers seeking oral peptide therapies. Public reporting has noted a focus on oral peptide treatments for autoimmune diseases. In late 2024, Nimble Therapeutics was acquired by AbbVie and integrated into AbbVie's operations.

Sign up for free to view info

Company overview Employee directory